ArticleBMC gastroenterology2022

NAPSB as a predictive marker for prognosis and therapy associated with an immuno-hot tumor microenvironment in hepatocellular carcinoma.

Yu-Mei Ning et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.